Factors associated with medication adherence to oral hypoglycaemic agents in different ethnic groups suffering from Type2 diabetes: A systematic literature review and suggestions for further research

Diabetic Medicine

Volumn 28, Issue 3, 2011, Pages 262-275

  Peeters, B ^a   Van Tongelen, I ^a   Boussery, K ^a   Mehuys, E ^a   Remon, J P ^a   Willems, S ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Adherence; Ethnicity; Methodology; Review; Type2 diabetes

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; CHLORPROPAMIDE; GLYCOSIDASE INHIBITOR; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; PIOGLITAZONE; SULFONYLUREA;

CULTURAL FACTOR; DIABETES MELLITUS; DISEASE DURATION; ETHNIC GROUP; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; REVIEW; SELF REPORT; SOCIOECONOMICS; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

DIABETES MELLITUS, TYPE 2; ETHNIC GROUPS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MEDICATION ADHERENCE; SELF CARE;

EID: 79851503501     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2010.03133.x     Document Type: Review

References (73)

1. Carter JS, Pugh JA, Monterrosa A. Non-insulin-dependent diabetes mellitus in minorities in the United States. Ann Intern Med 1996; 125: 221-232.
2. Dijkshoorn H, Uitenbroek DG, Middelkoop BJ. Prevalence of diabetes mellitus and cardiovascular disease among immigrants from Turkey and Morocco and the indigenous Dutch population. [in Dutch]. Ned Tijdschr Geneeskd 2003; 147: 1362-1366.
3. Ministry of Health. Modelling Diabetes: A Summary. Public Health Intelligence Occasional Bulletin No.11. Wellington: Ministry of Health, 2002.
4. Misra A, Ganda OP. Migration and its impact on adiposity and type2 diabetes. Nutrition 2007; 23: 696-708.
5. Egede LE, Dagogo-Jack S. Epidemiology of type2 diabetes: focus on ethnic minorities. Med Clin North Am 2005; 89: 949-75 viii.
6. Dagogo-Jack S. Ethnic disparities in type2 diabetes: pathophysiology and implications for prevention and management. J Natl Med Assoc 2003; 95: 774-789.
7. Vermeire E, Hearnshaw H, Ratsep A, Levasseur G, Petek D, van Dam H et al. Obstacles to adherence in living with type-2 diabetes: an international qualitative study using meta-ethnography (EUROBSTACLE). Prim Care Diabetes 2007; 1: 25-33.
8. Peyrot M, Rubin RR, Lauritzen T, Snoek FJ, Matthews DR, Skovlund SE. Psychosocial problems and barriers to improved diabetes management: results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) Study. Diabet Med 2005; 22: 1379-1385.
9. Gonzalez JS, Safren SA, Cagliero E, Wexler DJ, Delahanty L, Wittenberg E et al. Depression, self-care, and medication adherence in type2 diabetes: relationships across the full range of symptom severity. Diabetes Care 2007; 30: 2222-2227.
10. Rubin RR. Adherence to pharmacologic therapy in patients with type2 diabetes mellitus. Am J Med 2005; 118: 27-34.
11. Stack RJ, Elliott RA, Noyce PR, Bundy C. A qualitative exploration of multiple medicines beliefs in co-morbid diabetes and cardiovascular disease. Diabet Med 2008; 25: 1204-1210.
12. Grant RW, Devita NG, Singer DE, Meigs JB. Polypharmacy and medication adherence in patients with type2 diabetes. Diabetes Care 2003; 26: 1408-1412.
13. WHO. Adherence to Long-Term Therapies: Evidence for Action. Geneva: World Health Organization, 2003.
14. Greenhalgh T, Helman C, Chowdhury AM. Health beliefs and folk models of diabetes in British Bangladeshis: a qualitative study. Br Med J 1998; 316: 978-983.
15. Hjelm K, Bard K, Nyberg P, Apelqvist J. Religious and cultural distance in beliefs about health and illness in women with diabetes mellitus of different origin living in Sweden. Int J Nurs Stud 2003; 40: 627-643.
16. Pound P, Britten N, Morgan M, Yardley L, Pope C, Daker-White G et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc Sci Med 2005; 61: 133-155.
17. Heisler M, Faul JD, Hayward RA, Langa KM, Blaum C, Weir D. Mechanisms for racial and ethnic disparities in glycemic control in middle-aged and older Americans in the health and retirement study. Arch Intern Med 2007; 167: 1853-1860.
18. Barnes L, Moss-Morris R, Kaufusi M. Illness beliefs and adherence in diabetes mellitus: a comparison between Tongan and European patients. N Z Med J 2004; 117: 743-751.
19. Bean D, Cundy T, Petrie KJ. Ethnic differences in illness perceptions, self-efficacy and diabetes self-care. Psychol Health 2007; 22: 787-811.
20. Adams AS, Trinacty CM, Zhang F, Kleinman K, Grant RW, Meigs JB et al. Medication adherence and racial differences in A1C control. Diabetes Care 2008; 31: 916-921.
21. Schectman JM, Nadkarni MM, Voss JD. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care 2002; 25: 1015-1021.
22. Shenolikar RA, Balkrishnan R, Camacho FT, Whitmire JT, Anderson RT. Race and medication adherence in Medicaid enrollees with type-2 diabetes. J Natl Med Assoc 2006; 98: 1071-1077.
23. Sclar DA, Robison LM, Skaer TL, Dickson WM, Kozma CM, Reader CE. Sulfonylurea pharmacotherapy regimen adherence in a Medicaid population: influence of age, gender, and race. Diabetes Educ 1999; 25: 531-538.
24. Venturini F, Nichol MB, Sung JCY, Bailey KL, Cody M, McCombs JS. Compliance with sulfonylureas in a health maintenance organization: a pharmacy record-based study. Ann Pharmacother 1999; 33: 281-288.
25. Shenolikar RA, Balkrishnan R, Camacho FT, Whitmire JT, Anderson RT. Comparison of medication adherence and associated health care costs after introduction of pioglitazone treatment in African Americans versus all other races in patients with type2 diabetes mellitus: a retrospective data analysis. Clin Ther 2006; 28: 1199-1207.
26. Lee R, Taira DA. Adherence to oral hypoglycemic agents in Hawaii. Prev Chronic Dis 2005; 2: 1-7.
27. Lanting LC, Joung IM, Vogel I, Bootsma AH, Lamberts SW, Mackenbach JP. Ethnic differences in outcomes of diabetes care and the role of self-management behavior. Patient Educ Couns 2008; 72: 146-154.
28. Rothman RL, Mulvaney S, Elasy TA, VanderWoude A, Gebretsadik T, Shintani A et al. Self-management behaviors, racial disparities, and glycemic control among adolescents with type2 diabetes. Pediatrics 2008; 121: e912-e919.
29. Petticrew M, Roberts H. Systematic Reviews in the Social Sciences. Oxford: Blackwell, 2006.
30. Higgins J, Greene S. Cochrane Handbook for Systematic Reviews of Interventions, Version5.0.2. New York: Wiley, 2009.
31. Armstrong R, Waters E, Jackson N, Oliver S, Popay J, Shepperd J et al. Guidelines for Systematic Reviews of Health Promotion and Public Health Interventions. Version2. Melbourne: Melbourne University, 2007.
32. Centre for Reviews and Dissemination. Systematic Reviews. CDR's Guidance for Undertaking Reviews in Health Care. York: University of York, 2009.
33. Nathan D, Buse J, Davidson M, Ferrannini E, Holman R, Sherwin R et al. Medical management of hyperglycaemia in type2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Diabetologia 2009; 52: 17-30.
34. Zaza S, Wright-De Agüero LK, Briss PA, Truman BI, Hopkins DP, Hennessy MH et al. Data collection instrument and procedure for systematic reviews in the guide to community preventive services. Am J Prev Med 2000; 18: S44-74.
35. Kaplan JB, Bennett T. Use of race and ethnicity in biomedical publication. J Am Med Assoc 2003; 289: 2709-2716.
36. Hill-Briggs F, Gary TL, Hill MN, Levine DM, Brancati FL. Medication adherence and diabetes control in urban African Americans with type2 diabetes. Health Psychol 2005; 24: 349-357.
37. Kuo YF, Raji MA, Markides KS, Ray LA, Espino DV, Goodwin JS. Inconsistent use of diabetes medications, diabetes complications, and mortality in older Mexican Americans over a 7-year period: data from the Hispanic established population for the epidemiologic study of the elderly. Diabetes Care 2003; 26: 3054-3060.
38. Sarkar U, Fisher L, Schillinger D. Is self-efficacy associated with diabetes self-management across race/ethnicity and health literacy? Diabetes Care 2006; 29: 823-829.
39. Venter HL, Joubert PH, Foukaridis GN. Compliance in Black patients with non-insulin-dependent diabetes mellitus receiving oral hypoglycemic therapy. S Afr Med J 1991; 79: 549-551.
40. Aikens JE, Piette JD. Diabetes patients' medication underuse, illness outcomes, and beliefs about antihyperglycemic and antihypertensive treatments. Diabetes Care 2009; 32: 19-24.
41. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 2000; 160: 3278-3285.
42. Lin EH, Katon W, Von Korff M, Rutter C, Simon GE, Oliver M et al. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care 2004; 27: 2154-2160.
43. Odegard PS, Capoccia K. Medication taking and diabetes: a systematic review of the literature. Diabetes Educ 2007; 33: 1014-1029.
44. Lawton J, Ahmad N, Hallowell N, Hanna L, Douglas M. Perceptions and experiences of taking oral hypoglycaemic agents among people of Pakistani and Indian origin: qualitative study. Br Med J 2005; 330: 1247-1250.
45. Senior PA, Bhopal RS. Ethnicity as a variable in epidemiological research. Br Med J 1994; 309: 327-330.
46. LaVeist TA. Beyond dummy variables and sample selection: what health services researchers ought to know about race as a variable. Health Serv Res 1994; 29: 1-16.
47. Hahn RA, Stroup DF. Race and ethnicity in public health surveillance: criteria for the scientific use of social categories. Public Health Rep 1994; 109: 7-15.
48. Williams DR. Race and health: basic questions, emerging directions. Ann Epidemiol 1997; 7: 322-333.
49. Ford ME, Kelly A. Conceptualizing and categorizing race and ethnicity in health services research. Health Services Res 2005; 40: 1658-1675.
50. Bhopal RJ. Ethnicity, Race and Health in Multicultural Societies: Foundations for Better Epidemiology, Public Health and Health Care. Oxford: Oxford University Press, 2007.
51. Karter AJ. Race and ethnicity: vital constructs for diabetes research. Diabetes Care 2003; 26: 2189-2193.
52. Anonymous. Style matters: ethnicity, race, and culture: guidelines for research, audit, and publication. Br Med J 1996; 312: 1094.
53. McKenzie K, Crowcroft NS. Describing race, ethnicity, and culture in medical research. Br Med J 1996; 312: 1054-1055.
54. Ellison GT, Smart A, Tutton R, Outram SM, Ashcroft R, Martin P. Racial categories in medicine: A failure of evidence-based practice? PLoS Med 2007; 4: 1434-1436.
55. McAuley J, De Souza L, Sharma V, Robinson I, Main CJ, Frank AO. Self defined ethnicity is unhelpful. BMJ 1996; 313: 425-426.
56. Walsh ME, Katz MA, Sechrest L. Unpacking cultural factors in adaptation to type2 diabetes mellitus. Med Care 2002; 40: I-129-I-139.
57. Comstock RD, Castillo EM, Lindsay SP. Four-year review of the use of race and ethnicity in epidemiologic and public health research. Am J Epidemiol 2004; 159: 611-619.
58. Lee C. 'Race' and 'ethnicity' in biomedical research: how do scientists construct and explain differences in health? Soc Sci Med 2009; 68: 1183-1190.
59. Ma IW, Khan NA, Kang A, Zalunardo N, Palepu A. Systematic review identified suboptimal reporting and use of race/ethnicity in general medical journals. J Clin Epidemiol 2007; 60: 572-578.
60. Winker MA. Measuring race and ethnicity: Why and how? J Am Med Assoc 2004; 292: 1612-1614.
61. Rivara FP, Finberg L. Use of the terms race and ethnicity. Arch Pediatr Adolesc Med 2001; 155: 119.
62. Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research: a comprehensive review. J Clin Pharm Ther 2001; 26: 331-342.
63. Morisky DE, Green LW, Levine DM. Concurrent and predictive-validity of a self-reported measure of medication adherence. Med Care 1986; 24: 67-74.
64. Hess LM, Raebel MA, Conner DA, Malone DC. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother 2006; 40: 1280-1288.
65. Steiner JF, Koepsell TD, Fihn SD, Inui TS. A general-method of compliance assessment using centralized pharmacy records-description and validation. Med Care 1988; 26: 814-823.
66. Grymonpre RE, Didur CD, Montgomery PR, Sitar DS. Pill count, self-report, and pharmacy claims data to measure medication adherence in the elderly. Ann Pharmacother 1998; 32: 749-754.
67. Hansen RA, Kim MM, Song L, Tu W, Wu J, Murray MD. Comparison of methods to assess medication adherence and classify nonadherence. Ann Pharmacother 2009; 43: 413-422.
68. Cook CL, Wade WE, Martin BC, Perri M III. Concordance among three self-reported measures of medication adherence and pharmacy refill records. J Am Pharm Assoc 2005; 45: 151-159.
69. Brown K, Avis M, Hubbard M. Health beliefs of African-Caribbean people with type2 diabetes: a qualitative study. Br J Gen Pract 2007; 57: 461-469.
70. Choudhury SM, Brophy S, Williams R. Understanding and beliefs of diabetes in the UK Bangladeshi population. Diabet Med 2009; 26: 636-640.
71. Hunt LM, Arar NH, Akana LL. Herbs, prayer, and insulin. Use of medical and alternative treatments by a group of Mexican American diabetes patients. J Fam Pract 2000; 49: 216-223.
72. Schoenberg NE, Traywick LS, Jacobs-Lawson J, Kart CS. Diabetes self-care among a multiethnic sample of older adults. J Cross Cult Gerontol 2008; 23: 361-376.
73. Noblit G, Hare R. Meta-Ethnography: Synthesising Qualitative Studies. Newbury Park, CA: Sage, 1988.